Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cifaldi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
La Clinica Terapeutica|April 11, 2008
[Bioethics and pharmacoeconomics: a difficult balance]V Felicetti, G Cristina, L Cifaldi
La Clinica Terapeutica|July 1, 2010
[Informed consent. Doctor and patient: comparison of view points]V Felicetti, F Manfredi Selvaggi, L Cifaldi
La Clinica Terapeutica|September 26, 2012
[The perceived quality of routine daily communication in dialogues between health care workers]V Felicetti, L Cifaldi, G Cristina, et al.
La Clinica Terapeutica|October 2, 2009
[From empowerment to customer satisfaction: experience of a medical oncology unit]L Cifaldi, R Gareri, G Cristina, et al.
AIDS Research and Human Retroviruses|March 1, 1990
HTLV-I and HIV-1 infection in patients with lymphadenopathy syndrome detected during routine breast screening at a tumor prevention centerV Manzari, M Modesti, L De Marchis, et al.
Giornale Italiano Di Oncologia|October 1, 1990
[Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms]P Marchei, L Cifaldi, A De Benedetto, et al.
Cancer Research|April 20, 2001
Interleukin 12-activated lymphocytes influence tumor genetic programsF Cavallo, E Quaglino, L Cifaldi, et al.
Cancer Research|April 18, 2001
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasiaL Cifaldi, E Quaglino, E Di Carlo, et al.
Oncogene|April 25, 2012
ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axisF Galeano, C Rossetti, S Tomaselli, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
La Clinica Terapeutica|April 11, 2008
[Bioethics and pharmacoeconomics: a difficult balance]V Felicetti, G Cristina, L Cifaldi
La Clinica Terapeutica|July 1, 2010
[Informed consent. Doctor and patient: comparison of view points]V Felicetti, F Manfredi Selvaggi, L Cifaldi
La Clinica Terapeutica|September 26, 2012
[The perceived quality of routine daily communication in dialogues between health care workers]V Felicetti, L Cifaldi, G Cristina, et al.
La Clinica Terapeutica|October 2, 2009
[From empowerment to customer satisfaction: experience of a medical oncology unit]L Cifaldi, R Gareri, G Cristina, et al.
AIDS Research and Human Retroviruses|March 1, 1990
HTLV-I and HIV-1 infection in patients with lymphadenopathy syndrome detected during routine breast screening at a tumor prevention centerV Manzari, M Modesti, L De Marchis, et al.
Giornale Italiano Di Oncologia|October 1, 1990
[Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms]P Marchei, L Cifaldi, A De Benedetto, et al.
Cancer Research|April 20, 2001
Interleukin 12-activated lymphocytes influence tumor genetic programsF Cavallo, E Quaglino, L Cifaldi, et al.
Cancer Research|April 18, 2001
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasiaL Cifaldi, E Quaglino, E Di Carlo, et al.
Oncogene|April 25, 2012
ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axisF Galeano, C Rossetti, S Tomaselli, et al.
Pageof 1